iSonea Ltd (ASX:ISN US OTCQX: ISOAY), a healthcare technology company engaged in the research, development, and commercialization of medical devices and software utilizing smartphones and the Internet as the primary technology platform for monitoring and managing asthma, today announced that Michael Thomas, chief executive officer, will be presenting at the Inaugural Cappello Capital Corp. Australian U.S. Investor Conference at The Hyatt Regency Century Plaza in Los Angeles on Thursday, January 12 at 1:30 p.m. PT.
During this one day conference, U.S. investors will gain insight into Australian companies, both public and private, across a variety of sectors including healthcare, mining and energy.
Enquiries: iSonea Limited Mr. Michael Thomas Chief Executive Officer +1 410-777-5251 [email protected] www.iSoneaMed.com
ISN Price at posting:
12.0¢ Sentiment: Buy Disclosure: Held
